Evolent Health reported quarterly EPS of $0.02, beating the Zacks Consensus Estimate for a $0.01 loss. Results improved from a year-ago loss of $0.10 per share, signaling a meaningful profitability turnaround. The earnings beat is likely to support the stock by about 1–3% near term, though no guidance details were provided.
Evolent Health reported quarterly EPS of $0.02, beating the Zacks Consensus Estimate for a $0.01 loss. Results improved from a year-ago loss of $0.10 per share, signaling a meaningful profitability turnaround. The earnings beat is likely to support the stock by about 1–3% near term, though no guidance details were provided.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
